{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:43:08Z","timestamp":1790876588285,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.thromres.2013.10.040","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T02:21:13Z","timestamp":1383704473000},"page":"120-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Haplotypes of TAFI gene and the risk of cerebral venous thrombosis - a case-control study"],"prefix":"10.1016","volume":"133","author":[{"given":"Cristina M.","family":"Orikaza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia M.","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinez F.","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayse M.","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2013.10.040_bb0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1055\/s-0037-1613887","article-title":"Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale","volume":"83","author":"Oger","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.10.040_bb0010","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMra042354","article-title":"Thrombosis of the Cerebral Veins and Sinuses","volume":"352","author":"Stam","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2013.10.040_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11739-009-0329-1","article-title":"Cerebral vein thrombosis","volume":"5","author":"Dentali","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.thromres.2013.10.040_bb0020","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1182\/blood-2005-09-3578","article-title":"Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis","volume":"107","author":"Dentali","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.10.040_bb0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ng578","article-title":"Increased efficiency of mRNA 3\u2019end formation: a new genetic mechanism contributing to hereditary thrombophilia","volume":"28","author":"Gehring","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.thromres.2013.10.040_bb0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.thromres.2011.10.031","article-title":"Thrombin activatable fibrinolysis inhibitor: At the nexus of fibrinolysis and inflammation","volume":"129","author":"Colucci","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.10.040_bb0035","first-page":"510","article-title":"Identification of polymorphisms in the 5\u2019-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis","volume":"86","author":"Franco","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2013.10.040_bb0040","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1538-7836.2009.03350.x","article-title":"The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study","volume":"7","author":"de Bruijne","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.10.040_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1182\/blood-2007-03-078543","article-title":"Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis","volume":"111","author":"Boffa","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.10.040_bb0050","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1538-7836.2005.01486.x","article-title":"TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study","volume":"3","author":"Morange","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.10.040_bb0055","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood.V97.7.2053","article-title":"Identification of polymorphisms in the promoter and the 3\u2019 region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled","volume":"97","author":"Henry","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.10.040_bb0060","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.thromres.2011.04.016","article-title":"The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6 -174GC, IL-8 -251AT and MCP-1 -2518AG in the risk of venous thromboembolism: A case-control study","volume":"128","author":"Matos","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.10.040_bb0065","doi-asserted-by":"crossref","first-page":"e17063","DOI":"10.1371\/journal.pone.0017063","article-title":"The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected","volume":"16","author":"Pena","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2013.10.040_bb0070","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1182\/blood.V91.6.2208","article-title":"Rapid Simultaneous Screening of Factor V Leiden and G20210A Prothrombin Variant by Multiplex Polymerase Chain Reaction on Whole Blood","volume":"91","author":"Gomez","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.10.040_bb0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-0037-1613604","article-title":"Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris The APRAIS study","volume":"90","author":"Brouwers","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.10.040_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barret","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.thromres.2013.10.040_bb0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.thromres.2006.01.008","article-title":"A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATROS (Brazilian Thrombosis Study)","volume":"119","author":"Pereira","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.10.040_bb0090","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/STROKEAHA.110.602672","article-title":"Genes Associated With Adult Cerebral Venous Thrombosis","volume":"42","author":"Marjot","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2013.10.040_bb0095","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1538-7836.2004.00785.x","article-title":"Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian","volume":"2","author":"Rodrigues","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.10.040_bb0100","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1182\/blood.V95.9.2855.009k02_2855_2859","article-title":"Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis","volume":"95","author":"van Tilburg","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.10.040_bb0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2141.2006.06117.x","article-title":"The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis","volume":"134","author":"Martini","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2013.10.040_bb0110","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1538-7836.2009.03715.x","article-title":"Hypofibrinolysis as a risk factor for recurrent venous thrombosis; results of the LETS follow-up study","volume":"8","author":"Meltzer","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.10.040_bb0115","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(02)07813-3","article-title":"Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state","volume":"359","author":"Ari\u00ebns","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2013.10.040_bb0120","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1074\/jbc.M104444200","article-title":"Two Naturally Occurring Variants of TAFI (Thr-325 and Ile-325) Differ Substantially with Respect to Thermal Stability and Antifibrinolytic Activity of the Enzyme","volume":"277","author":"Schneider","year":"2002","journal-title":"J Biol Chem"},{"issue":"3S","key":"10.1016\/j.thromres.2013.10.040_bb0125","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1378\/chest.124.3_suppl.33S","article-title":"Thrombin and fibrinolysis","volume":"124","author":"Nesheim","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2013.10.040_bb0130","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1055\/s-0037-1615394","article-title":"Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms","volume":"80","author":"Zhao","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.10.040_bb0135","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1182\/blood.V98.6.1992","article-title":"A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels","volume":"98","author":"Brouwers","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.10.040_bb0140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00415-005-0988-4","article-title":"Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems","volume":"253","author":"Lichy","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.thromres.2013.10.040_bb0145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s13760-012-0170-6","article-title":"TAFI gene polymorphisms in patients with cerebral venous thrombosis","volume":"113","author":"Tokgoz","year":"2013","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.thromres.2013.10.040_bb0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00439-008-0527-3","article-title":"A genome-wide exploration suggests an oligogenic model of inheritance for TAFI activity and its antigen levels","volume":"124","author":"Sabater-Lleal","year":"2008","journal-title":"Hum Genet"},{"key":"10.1016\/j.thromres.2013.10.040_bb0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1471-2164-11-223","article-title":"g you The direct determination of haplotypes from extended regions of genomic DNA","volume":"11","author":"Stirling","year":"2010","journal-title":"BMC Genomics"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481300515X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481300515X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T11:17:24Z","timestamp":1596799044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938481300515X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S004938481300515X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.10.040","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haplotypes of TAFI gene and the risk of cerebral venous thrombosis - a case-control study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.10.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}